| p53 isoforms: key regulators of the cell fate decision SM Joruiz, JC Bourdon Cold Spring Harbor perspectives in medicine 6 (8), a026039, 2016 | 203 | 2016 |
| TP53 drives invasion through expression of its Δ133p53β variant G Gadea, N Arsic, K Fernandes, A Diot, SM Joruiz, S Abdallah, V Meuray, ... Elife 5, e14734, 2016 | 66 | 2016 |
| The Δ133p53β isoform promotes an immunosuppressive environment leading to aggressive prostate cancer M Kazantseva, S Mehta, RA Eiholzer, G Gimenez, S Bowie, H Campbell, ... Cell death & disease 10 (9), 631, 2019 | 50 | 2019 |
| Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumor development M Kazantseva, RA Eiholzer, S Mehta, A Taha, S Bowie, I Roth, J Zhou, ... The Journal of pathology 246 (1), 77-88, 2018 | 48 | 2018 |
| MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer M Gayral, S Jo, N Hanoun, A Vignolle-Vidoni, H Lulka, Y Delpu, A Meulle, ... World Journal of Gastroenterology: WJG 20 (32), 11199, 2014 | 48 | 2014 |
| The Δ133p53 isoforms, tuners of the p53 pathway SM Joruiz, JA Beck, I Horikawa, CC Harris Cancers 12 (11), 3422, 2020 | 31 | 2020 |
| Chalret du Rieu M, Bournet B, Selves J, Guimbaud R, Carrere N, Buscail L, Torrisani J, Cordelier P: MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer M Gayral, S Jo, N Hanoun, A Vignolle-Vidoni, H Lulka, Y Delpu, A Meulle, ... World J Gastroenterol 20 (32), 11199-209, 2014 | 8 | 2014 |
| Δ133p53α protects human astrocytes from amyloid-beta induced senescence and neurotoxicity K Ungerleider, JA Beck, D Lissa, S Joruiz, I Horikawa, CC Harris Neuroscience 498, 190-202, 2022 | 5 | 2022 |
| p53 Isoforms: key regulators of the cell fate decision. Cold Spring Harb Perspect Med. 2016 SM Joruiz, JC Bourdon | 5 | |
| PO-059 Cancer-predisposing variants in alternatively spliced TP53 exons SA Schubert, N De Miranda, D Ruano, D Barge-Schaapveld, FJ Hes, ... ESMO Open 3, A249-A250, 2018 | 1 | 2018 |
| Germline variant affecting p53β isoforms predisposes to familial cancer SA Schubert, D Ruano, SM Joruiz, J Stroosma, N Glavak, A Montali, ... Nature Communications 15 (1), 8208, 2024 | | 2024 |
| Distinct functions of wild-type and R273H mutant Δ133p53α differentially regulate glioblastoma aggressiveness and therapy-induced senescence SM Joruiz, N Von Muhlinen, I Horikawa, MR Gilbert, CC Harris Cell Death & Disease 15 (6), 454, 2024 | | 2024 |
| Targeting Delta133p53 isoform with small-molecule compounds to modulate cellular senescence D Lissa, K Ungerleider, I Horikawa, P Dranchak, E Oliphan, J Beck, S Jo, ... Clinical Cancer Research 26 (12_Supplement_1), 19-19, 2020 | | 2020 |
| Live cell and in vitro analysis of p53 interactions L Yurlova, A Buchfellner, B Ruf, SGM Jo, JC Bourdon, FJ Ghadessy, ... Cancer Research 75 (15_Supplement), 1231-1231, 2015 | | 2015 |
jean-christophe bourdonDirector of Research, University of Dundee, UK在 dundee.ac.uk 的电子邮件经过验证
